Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2019-07-02 Legal Proceedings Report
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
GILEAD KONDIGT PLAN AAN OM DIT JAAR EEN VERGUNNINGSDOSSIER VOOR FILGOTINIB IN TE DIENEN BIJ DE FDA
Legal Proceedings Report Classification · 99% confidence The document is a press release dated July 2, 2019, originating from Mechelen, Belgium, and is explicitly labeled as 'gereglementeerde informatie' (regulated information). The content discusses Gilead Sciences and Galapagos providing an update to the FDA regarding the regulatory pathway for the drug filgotinib, including plans to submit a filing dossier later that year. This type of announcement, detailing significant operational or regulatory milestones (like drug development updates or planned submissions) released via press release, typically falls under general regulatory announcements or investor relations material. Since it is not a full financial report (10-K, IR), a specific financial result announcement (ER), or a proxy/governance document, it best fits the category for general regulatory announcements or investor communications. Given the context of providing updates on regulatory progress and referencing SEC filings in the forward-looking statements, it aligns closely with an Investor Presentation (IP) or a general Regulatory Filing (RNS). Because it is a formal press release announcing a significant business/regulatory event rather than a detailed presentation deck, RNS (Regulatory Filings) is the most appropriate general category for non-standard, time-sensitive regulatory news, although it contains elements of an Investor Presentation summary. However, since it is a formal press release announcing a regulatory update and referencing future filings, and does not fit the specific financial/governance codes, RNS is the best fit as a general regulatory announcement.
2019-07-02 Dutch
6-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Galapagos NV. It references a press release dated July 2, 2019, attached as Exhibit 99.1. The document length is only 2597 characters, which is quite short and primarily serves as a cover report to submit the press release. There is no substantive financial data or detailed report content within this filing. According to the rules, such short filings that mainly announce or attach other reports or press releases should be classified as Regulatory Filings (RNS).
2019-07-02 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces a capital increase ('kapitaalverhoging') resulting from the exercise of warrants, leading to the issuance of new shares and a change in the total number of voting rights. This directly relates to changes in the company's capital structure and financing activities. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it mentions transparency rules regarding share capital, the core event is the capital raise, not a general governance report or a major shareholding notification (MRQ). It is not a short announcement linking to a larger report, so RPA/RNS is less appropriate than CAP.
2019-06-21 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces a 'share capital increase arising from warrant exercises' and details the issuance of new ordinary shares and the resulting change in total share capital and voting rights. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it concerns a specific corporate action related to equity.
2019-06-21 English
6-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Galapagos NV, for June 2019. It references an attached press release (Exhibit 99.1) dated June 20, 2019. The document length is only 2600 characters, which is short and primarily serves to announce the filing of the press release. There is no substantive financial data or detailed report content within this text. According to the rules, such a short document that announces or attaches a report or press release is classified as a Regulatory Filing (RNS) rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-06-21 English
Share Capital Increase - 20-Jun-2019 - EN.pdf
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces a 'share capital increase arising from warrant exercises' and details the issuance of new ordinary shares and the resulting change in total share capital and voting rights. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it concerns a specific corporate action related to equity.
2019-06-20 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.